2015 Top 20 Companies: Sanofi
10. Sanofi $14.6B ▲19.9% Global revenue: $40B (3rd); up 8.1%Top brands: Lantus Solostar ($4.5B); Lantus ($3.4B); Renagel/Renvela ($491M); Aubagio ($345M); Synvisc/Synvisc-One ($290M)Promotional spend: $456M (15th); 3.1% of rev. R&D spend: $5B (6th); up 2%; 12.5% of rev.Planned launches: alirocumab (CV); sarilumab (RA); lixisenatide (diabetes)Patent expirations: Aubagio (2017); Multaq (2018); Toujeo (2018) Sanofi’s new CEO Olivier Brandicourt,…